Back to Search Start Over

A phase 1/2 trial of a vaporized 5-Methoxy-N,N-Dimethyltryptamine formulation, in patients with treatment-resistant depression

Authors :
J. Reckweg
C. van Leeuwen
C. Henquet
T. van Amelsvoort
E.L. Theunissen
N.L. Mason
R. Paci
T.H. Terwey
J.G. Ramaekers
Source :
Neuroscience Applied. 1:100515
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Details

ISSN :
27724085
Volume :
1
Database :
OpenAIRE
Journal :
Neuroscience Applied
Accession number :
edsair.doi...........de722f6786f938ef9bb4b655a4ae21e3